Stage FocusSeed, Series A
GeographySoutheast Asia
TypeGovernment
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeGovernment Fund
ExposureMostly DeepTech Investments
Bio
ClavystBio was established in 2021 by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek — Singapore's sovereign wealth fund. Since 2022, the firm has committed over $220M to biotech, diagnostics, and digital health companies, with 23 total investments including 11 direct companies and 3 early-stage VC fund positions.
Focus areas include cell and gene therapy, biomarkers, digital heal...
Notable Investments
N
NSG BioLabsSimilar Funds
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedTechSynthetic BiologySeedSeries A
Atlas Venture
Cambridge, United States
Pure DeepTechBiotechSynthetic BiologyMedTechSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantum ComputingSemiconductorsSeedSeries A
Deep Insight
Herzliya, Israel
Pure DeepTechBiotechSemiconductorsRoboticsSeedSeries A
Longwood Fund
Boston, United States
Pure DeepTechBiotechMedTechPre-SeedSeed